COMMUNIQUÉS West-GlobeNewswire

Akari Therapeutics Discusses Breakthrough Potential of AKTX-101 and Novel Spliceosome-Modulating ADC Platform in Virtual Investor “What This Means” Segment Following ASCO Abstract Acceptance
28/05/2026
CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers Watch the “What This Means” video here TAMPA, Fla. and LONDON, May 28, 2026 (GLOBE NEWSWIRE [...]
H1 Receives $40M Investment in Round Led by CVS Health Ventures
28/05/2026
H1 helps healthcare players transform operations with AI NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- H1 recently received a $40M investment in a round led by CVS Health Ventures , the venture capital investment platform [...]
Pemvidutide Demonstrates Significant Metabolic Improvements in Patients with MASH in New 48‑Week IMPACT Phase 2b Data Presented at EASL 2026
28/05/2026
“Best of EASL” oral presentation highlights meaningful reductions in triglycerides, cholesterol, and blood pressure, along with improvements in key metabolic risk factors PERFORMA Phase 3 trial to further evaluate the [...]
Serotonin Centers Opens in Lake Nona, Expanding Physician-Led Longevity Care into One of the Nation’s Leading Health Innovation Communities
28/05/2026
New Location Aligns with Growing Demand for Data-Driven Wellness, Hormone Optimization and Advanced Recovery Therapies ORLANDO, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science- [...]
Range Impact Announces West Virginia Attorney and Business Advisor Michael Simon Has Joined the Company as a Strategic Advisor
28/05/2026
CLEVELAND, OHIO, May 28, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing distressed coal mine properties [...]
ProMIS Neurosciences to Participate in Upcoming Conferences in June
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in [...]
Enlivex Treasury Portfolio Update: RAIN Holdings Valued at Approximately $1.16 Billion; Rain Foundation Appoints Industry Leaders to Advisory Board
28/05/2026
As of May 27, 2026, Enlivex held 79,568,550,005 RAIN tokens with a total value of approximately $1.16 billion. Separately, the Rain Foundation recently announced the appointment of five industry leaders to its advisory [...]
Prime Medicine to Present at Jefferies Global Healthcare Conference
28/05/2026
CAMBRIDGE, Mass., May 28, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
28/05/2026
ZUG, Switzerland and BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team are scheduled to participate in the following investor [...]
World Trade Center Health Program Launches National Awareness Initiative to Reach Those Who Were Impacted by 9/11 as Children or Teens
28/05/2026
New outreach initiative features New York City sketch artist and influencer Devon Rodriguez to reach individuals impacted by 9/11 at an early age and help them understand they may be eligible for no-cost medical [...]
Oruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
28/05/2026
MENLO PARK, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment [...]
Sol-Gel Reports First Quarter 2026 Financial Results and Provides Corporate Updates
28/05/2026
Sol-Gel received a Notice of Allowance for a method-of-use patent extending intellectual property protection for topical patidegib (SGT-610) until 2044 Sol-Gel completed an oversubscribed underwritten offering, raising [...]
Jushi Holdings Inc. Announces Applications Submitted for DEA Registration of State-Licensed Medical Cannabis Operations
28/05/2026
BOCA RATON, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) (OTCQX: JUSHF ) , a vertically integrated, multi-state cannabis operator, today announced that it has [...]
SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum
28/05/2026
TEL AVIV, Israel, May 28, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Entera’s EB613, First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis - Single Tablet Data Selected for Late Breaking Oral Presentation at ENDO 2026 Annual Meeting; Additional Oral Peptide Pipeline Data Accepted for Presentation
28/05/2026
TEL AVIV, May 28, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that multiple abstracts across its oral peptide [...]
FOXO TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
28/05/2026
WEST PALM BEACH, FL and MINNETONKA, MN, May 28, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”) and LongevityFP Technologies, LLC. (“LFP”) today jointly announced a strategic partnership to [...]
Artiva Biotherapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
28/05/2026
SAN DIEGO, May 28, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with [...]
Eupraxia Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
28/05/2026
VANCOUVER, British Columbia, May 28, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary [...]
Conavi Medical Reports Fiscal Second Quarter 2026 Results and Operational Highlights
28/05/2026
- Achieves U.S. FDA 510(k) Clearance for Next-Generation Hybrid IVUS-OCT Imaging System - Wins Multiple Industry Awards Recognizing Innovation and Leadership in Intravascular Imaging - Advances U.S. Commercial Readiness [...]

Pages